Currently set to Index
Currently set to Follow
search
ask age2b
CART 0

Science Prostate cancer

The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis
November 7, 2021
0
0
Zhipeng Wang 1, Yuchao Ni 1, Junru Chen 1, Guangxi Sun 1, Xingming Zhang 1, Jinge Zhao 1, Xudong Zhu 1, Haoran Zhang 1, Sha Zhu 1, Jindong Dai 1, Pengfei Shen 2, Hao Zeng 3 Main idea: prostatectomy could prolong the survival time of patients with high-risk prostate cancer; however, radiotherapy could delay the […]
Read more
The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis
November 7, 2021
0
0
Yuqiu Ge 1, Qianqian Shi 2, Wenxi Yao 1, Yang Cheng 3, Gaoxiang Ma 4 5 Affiliations expand Main idea: Our findings based on the large and multicenter samples strongly indicated that men with IBD  especial UC have significantly elevated prostate cancer risk. Future efforts are needed to define the mechanism underlying the link between […]
Read more
PSMA-targeted Radiotracers versus 18 F Fluciclovine for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis
November 7, 2021
0
0
Nelly Tan 1, Udochukwu Oyoyo 1, Niusha Bavadian 1, Nicholas Ferguson 1, Anudeep Mukkamala 1, Jeremie Calais 1, Matthew S Davenport 1 Main idea: Patient-level detection rates for biochemically recurrent prostate cancer were greater for prostate-specific membrane antigen-targeted radiotracers than fluciclovine for prostate specific antigen levels of 1.0-1.9 ng/mL. Abstract Background National guidelines endorse fluorine […]
Read more
Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis
November 7, 2021
0
0
Tina Jakob 1, Yonas Mehari Tesfamariam 1, Sascha Macherey 2, Kathrin Kuhr 3, Anne Adams 3, Ina Monsef 1, Axel Heidenreich 4, Nicole Skoetz 5 Main idea: When considering bone-modifying agents as supportive treatment, one has to balance between efficacy and acceptability. Results suggest that Zoledronic acid likely increases both the proportion of participants with […]
Read more
Association of gene polymorphisms of KLK3 and prostate cancer: A meta-analysis
November 7, 2021
0
0
Huifeng Li 1, Xiawei Fei 1, Yanting Shen 2, Zhenqi Wu 1 Main idea: Ten single nucleotide polymorphisms may be valuable as biomarkers for prostate cancer in the future. Abstract Previous studies have suggested that prostate-specific antigen (PSA) plays a role in the etiology of prostate cancer (PCa), and that polymorphisms of KLK3 may be […]
Read more
Prognostic value of alkaline phosphatase in hormone-sensitive prostate cancer: a systematic review and meta-analysis
November 7, 2021
0
0
Keiichiro Mori 1 2, Florian Janisch 1 3, Mehdi Kardoust Parizi 1 4, Hadi Mostafaei 1 5, Ivan Lysenko 1, Dmitry V Enikeev 6, Shoji Kimura 1 2, Shin Egawa 2, Shahrokh F Shariat Main idea: In this meta-analysis, elevated serum levels of alkaline phosphatase were associated with an increased risk of overall mortality and […]
Read more
Moderators of the effect of psychosocial interventions on fatigue in women with breast cancer and men with prostate cancer: Individual patient data meta-analyses
November 7, 2021
0
0
Harriët J G Abrahams 1, Hans Knoop 1, Maartje Schreurs 2, Neil K Aaronson 3, Paul B Jacobsen 4, Robert U Newton 5, Kerry S Courneya 6, Joanne F Aitken 7 8 9 10, Cecilia Arving 11, Yvonne Brandberg 12, Suzanne K Chambers 7 13 14 15, Marieke F M Gielissen 16, Bengt Glimelius 17, […]
Read more
Association between Postoperative Detection of Circulating Tumor Cells and Recurrence in Patients with Prostate Cancer
November 7, 2021
0
0
Sahyun Pak 1, Yoon Seok Suh 1 2, Dong-Eun Lee 3, Sung Han Kim 1, Jae Young Joung 1, Weon Seo Park 4, Sang-Jin Lee 5, Kang Hyun Lee 1 Main idea: Circulating tumor cells in the blood were frequently detected in patients with undetectable prostate specific antigen levels after radical prostatectomy for localized prostate […]
Read more
Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years: A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
November 7, 2021
0
0
Evan Kovac 1 2, Sigrid V Carlsson 3 4 5, Hans Lilja 4 6 7 8 9, Jonas Hugosson 5, Michael W Kattan 10, Erik Holmberg 11, Andrew J Stephenson 12 Main idea: In this secondary analysis of a cohort from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, baseline PSA levels among men […]
Read more
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
November 7, 2021
0
0
Emmanuel S Antonarakis 1, Josep M Piulats 2, Marine Gross-Goupil 3, Jeffrey Goh 4 5, Kristiina Ojamaa 6, Christopher J Hoimes 7, Ulka Vaishampayan 8, Ranaan Berger 9, Ahmet Sezer 10, Tuomo Alanko 11, Ronald de Wit 12, Chunde Li 13, Aurelius Omlin 14, Giuseppe Procopio 15, Satoshi Fukasawa 16, Ken-Ichi Tabata 17, Se Hoon […]
Read more

Ask your question

We read all your emails and your text. Your question will be responded by our specialists, or one of the doctors we're working with, or our community

Please complete the required fields.